Search Results1-20 of  32

  • 1 / 2
  • Doi Toshihiko ID: 9000241506342

    Articles in CiNii:1

    • Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer : subset analyses of the AVAGAST study and the ToGA study (2013)
  • Doi Toshihiko ID: 9000241612848

    Articles in CiNii:1

    • Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patients (2013)
  • Doi Toshihiko ID: 9000329006944

    Articles in CiNii:1

    • Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW : a randomized clinical trial in second-line treatment of gastric cancer (2016)
  • Doi Toshihiko ID: 9000356547271

    Articles in CiNii:1

    • Dose-escalation study for the targeting of CD44v⁺ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205) (2017)
  • Doi Toshihiko ID: 9000356647882

    Articles in CiNii:1

    • Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients (2017)
  • Doi Toshihiko ID: 9000356648249

    Articles in CiNii:1

    • Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials (2017)
  • Doi Toshihiko ID: 9000375852847

    Articles in CiNii:1

    • Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407) (2017)
  • Doi Toshihiko ID: 9000390405154

    Articles in CiNii:1

    • Regional differences in advanced gastric cancer : exploratory analyses of the AVAGAST placebo arm (2018)
  • Doi Toshihiko ID: 9000399574761

    Articles in CiNii:1

    • Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer (2019)
  • Doi Toshihiko ID: 9000403259727

    Articles in CiNii:1

    • Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer (2019)
  • Doi Toshihiko ID: 9000403259779

    Articles in CiNii:1

    • Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer : the JAVELIN Solid Tumor JPN trial (2019)
  • Doi Toshihiko ID: 9000403259814

    Articles in CiNii:1

    • Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma : results from the phase Ⅱ nonrandomized KEYNOTE-059 study (2019)
  • DOI Toshihiko ID: 9000001019710

    Department of Internal Medicine, National Shikoku Cancer Center (2003 from CiNii)

    Articles in CiNii:4

    • Analysis of Anxiety in Cancer Patients : The Effects of Telling the Truth (1996)
    • Circulating vascular endothelial growth factor(VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma (1998)
    • Evaluation of endoscopic injection sclerotherapy with and without simultaneous ligation for the treatment of esophageal varices (1999)
  • DOI Toshihiko ID: 9000002000574

    Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East (2010 from CiNii)

    Articles in CiNii:6

    • Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences (2007)
    • Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan : a retrospective review of 48 patients with metastatic colorectal cancer (2008)
    • Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene (2009)
  • DOI Toshihiko ID: 9000002941767

    Articles in CiNii:38

    • Two independent phase I trials of NK012, SN-38 incorporating micellar nanoparticle for patients with advanced cancer, opened in Japan and United States of America (2009)
    • Molecular Targeting Drug for GI Malignancy (2008)
    • 放射線・化学療法の立場から (診療controversy--medical decision makingのために 胃悪性リンパ腫に対する外科切除の役割は終わったか?) (2005)
  • DOI Toshihiko ID: 9000021412454

    The First Department of Internal Medicine, Okayama University Medical School (1992 from CiNii)

    Articles in CiNii:1

    • Analysis of liver histology of chronic non-A, non-B hepatitis treated with interferon. (1992)
  • DOI Toshihiko ID: 9000022119051

    The First Department of Internal Medicine, Okayama University Medical School (1992 from CiNii)

    Articles in CiNii:1

    • Four Cases with Intrafamilial Clustering of Hepatitis C Virus Infection. (1992)
  • DOI Toshihiko ID: 9000253803936

    Department of Anesthesiology, Takamatsu Red Cross Hospital (2004 from CiNii)

    Articles in CiNii:2

    • Noninvasive positive pressure ventilation for a patient with pulmonary edema after cesarean section (2003)
    • Lactic acidosis in a diabetic treated with buformin (2004)
  • DOI Toshihiko ID: 9000256340795

    First Department of Internal Medicine, Okayama University Medical School (1993 from CiNii)

    Articles in CiNii:1

    • A CASE OF CHRONIC HEPATITIS C MANIFESTED DISAPPEARANCE OF REDDISH MARKINGS ON THE LIVER SURFACE AFTER INTERFERON THERAPY (1993)
  • DOI Toshihiko ID: 9000256562478

    The First Department of Internal Medicine, Okayama University Medical School (1993 from CiNii)

    Articles in CiNii:1

    • An Epidemiological Study on Chronicity and Incidence of Hepatocellular Carcinoma in the Sequence of Epidemic Hepatitis (1993)
  • 1 / 2
Page Top